Since its founding in 2016, Iktos has established 45 collaborations with pharma/biotech companies and research institutes, including Janssen, Merck KGaA, Merck & Co./MSD, Pfizer, Hengrui Pharma, Chiesi, Alkermes, Zealand Pharma, Galapagos, Blueprint Medicines, Kadmon, Facio Therapies, Grünenthal, UCB, Leo Pharma, Orion, Almirall, SRI International and other undisclosed ones.